Skip to content
INVU Pro

Investors

The first FDA-cleared wearable for a non-stress test (NST) the mother takes at home.*

Invest in the future of maternal healthcare

Cleared to monitor.
Built to learn.

INVU™ lets a pregnant woman run a non-stress test herself, at home. Every session records the mother's heart, the baby's heart and uterine activity: multichannel pregnancy data that is rarely collected outside a hospital.

3FDA 510(k) clearances since 2020
25,000+remote monitoring sessions**
450,000+minutes of monitoring data**

Due diligence

Team, data, protection and proof

The teamLeadershipThe management team, the chairman and the advisory board of clinicians and healthcare executives.Meet the team → The dataINVU™ Data LakeWhat every monitoring session adds to Nuvo's pregnancy dataset, and why it is hard to replicate.Explore the data → The protectionIntellectual propertyThe patent portfolio behind the INVU™ belt, its signal processing and its software.See the portfolio →
RegulatoryFDA clearancesThree FDA 510(k) clearances, 2020–2022→The technologyHow INVU worksSensors on the belt, signals in the cloud, a read-out for the clinician→AccuracyValidated against the standardAgreement with hospital monitoring, in peer-reviewed journals→EvidenceClinical evidenceEvery published study and abstract, in one place→Real-world useUsed at homeHigh-risk pregnancies, monitored remotely→Independent researchCited by other researchersStudies and reviews that chose or cite INVU™→PartnersPartnershipsThe Nuvo–CLAW global health access programme→What is happening nowAnnouncementsNew partners, providers and programmes→In depthNewsroomThe stories behind the technology, with coverage and events→
Get in touchQuestions about Nuvo? Write to info@nuvocares.com
Email us →

*INVU™ by Nuvo is FDA-cleared (510(k) K210025 and K221046) for remote, self-administered monitoring of fetal heart rate, maternal heart rate and uterine activity for non-stress testing, from 32 weeks of pregnancy. **As reported by Nuvo, October 2026. Important information. This page is provided for general information about Nuvo Intl Group Inc. ("Nuvo") only. It is not an offer to sell, or a solicitation of an offer to buy, any securities of Nuvo, and should not be relied on in making any investment decision. Any offer of securities will be made only through definitive offering documents, to persons who qualify, and only where permitted by law. Submitting an inquiry creates no obligation for the submitter or Nuvo. Statements about future plans, products, markets and opportunities are forward-looking; they involve risks and uncertainties, and actual results may differ materially (see Forward-Looking Statements). Nothing on this page is investment, legal or tax advice.